Volta Clinical Evidence Roadmap

One of the most ambitious clinical programs focused on the underserved complex Atrial Fibrillation (AF) patient
The Problem
Underserved population of Complex AFib Patients

70%

of all AFib patients suffer from complex AF1

<50%

of catheter ablation treatments are persistent AF patients2
Our Approach
Industry-Leading Research Scope and quality
Published
2017
AF Ablation Guided by Spatiotemporal Electrogram Dispersion Whithout Pulmonary Vein Isolation
2022
Ev-AIFib
Artificial intelligence software standardizes electrogram-based ablation outcome for persistent atrial fibrillation
2025
The Tailored-AF Trial
Multicenter RCT
READ THE CLinical Summary
ACCESS THE FULL STUDY
Enrollment completed
RESTART Trial
Multicenter Prospective Study for Redo Procedures
READ more about the trial
Ongoing
Clinical Registry
Multicenter Prospective Study